Rare Disease and the Diagnostic Odyssey

05.23.2019 - By Illumina Genomics Podcast

Download our free app to listen on your phone

Rare diseases affect millions of people around the world. Dr. Matt Might is Professor and Director of the Hugh Kaul Precision Medicine Institute at the University of Alabama Birmingham. His son, Bertrand, was the first person to be diagnosed with NGLY1 deficiency, an ultra-rare disorder. Matt joined me to discuss Bertrand’s diagnostic odyssey and the impact of genomics on rare disease research.

More episodes from Illumina Genomics Podcast